MDGL Competitors & Alternatives
Compare Madrigal Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
MDGL
Main Stock$516.59
Tradestie Score
60
Market Cap
$10.01B
Revenue Growth
1.3%
Analyst Upside
+31.4%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$235.86
|
$12.36B | 26.4 | 56 | Compare |
|
EXEL
Exelixis Inc
|
$51.59
|
$11.09B | 17.2 | 60 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$31.46
|
$10.76B | - | 60 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$62.28
|
$10.74B | - | 65 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.35
|
$10.53B | 39.3 | 59 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$77.06
|
$10.49B | - | 66 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$69.73
|
$10.22B | - | 64 | Compare |
|
TECH
Bio-Techne Corp.
|
$56.65
|
$9.33B | 82.8 | 55 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$81.18
|
$8.88B | 228.3 | 56 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$69.95
|
$8.77B | 24.1 | 60 | Compare |
More MDGL Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry